IP Library Assignment 061695/0906
Patent Assignment
Reel/Frame 061695/0906

Assignment of Assignor's Interest

Recorded: 2022-11-08 Pages: 5
Assignors
NEALE, ANN
Executed: 2020-10-06
THOMAS, DOLCA
Executed: 2020-10-06
Assignee
PRINCIPIA BIOPHARMA INC.
220 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Property (1)
Method of Treating Pemphigus by Administering (R)-2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)Pyrazolo[3,4-D]Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2-Enenitrile
Application: 17/957,073 →
Publication: US 2023/0158033
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignee Change of Address Sep 16, 2025
From: PRINCIPIA BIOPHARMA INC.
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 072881/0270 →